%0 Journal Article
%T Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
%A Rittmeyer, Achim
%A Barlesi, Fabrice
%A Waterkamp, Daniel
%A Park, Keunchil
%A Ciardiello, Fortunato
%A von Pawel, Joachim
%A Gadgeel, Shirish M
%A Hida, Toyoaki
%A Kowalski, Dariusz M
%A Dols, Manuel Cobo
%A Cortinovis, Diego L
%A Leach, Joseph
%A Polikoff, Jonathan
%A Barrios, Carlos
%A Kabbinavar, Fairooz
%A Frontera, Osvaldo Arén
%A De Marinis, Filippo
%A Turna, Hande
%A Lee, Jong-Seok
%A Ballinger, Marcus
%A Kowanetz, Marcin
%A He, Pei
%A Chen, Daniel S
%A Sandler, Alan
%A Gandara, David R
%A ,
%J The Lancet
%@ 0140-6736
%D 2017-01-01
%I Elsevier BV
%~ DeepDyve